Critical Reviews in Therapeutic Drug Carrier Systems
译名:治疗药物载体系统评论
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS
1-3
2026
影响因子区间
—
平台估算
0%
2025
中国作者发文占比
—
收费
期刊简介:Therapeutic uses of a variety of drug carrier systems have significant impact on the treatment and potential cure of many chronic diseases, including cancer, diabetes mellitus, psoriasis, parkinsons, Alzheimer, rheumatoid arthritis, HIV infection, infectious diseases, asthma, and drug addiction. Scientific efforts in these areas are multidisciplinary, involving the physical, biological, medical, pharmaceutical, biological materials, and engineering fields.Articles concerning this field appear in a wide variety of journals. With the vast increase in the number of articles and the tendency to fragment science, it becomes increasingly difficult to keep abreast of the literature and to sort out and evaluate the importance and reliability of the data, especially when proprietary considerations are involved. Abstracts and noncritical articles often do not provide a sufficiently reliable basis for proper assessment of a given field without the additional perusal of the original literature. This journal bridges this gap by publishing authoritative, objective, comprehensive multidisciplinary critical review papers with emphasis on formulation and delivery systems. Both invited and contributed articles are subject to peer review.
【译文】各种药物载体系统的治疗用途对许多慢性疾病的治疗和潜在治愈具有重大影响,包括癌症、糖尿病、银屑病、帕金森病、阿尔茨海默病、类风湿性关节炎、HIV感染、传染病、哮喘和药物成瘾。这些领域的科学努力是多学科的,涉及物理、生物、医学、制药、生物材料和工程领域。有关该领域的文章出现在各种期刊上。随着文章数量的激增和科学的碎片化趋势,跟上文献的步伐以及筛选和评估数据的重要性和可靠性变得越来越困难,尤其是在涉及专有信息的情况下。摘要和非关键文章通常不能为对某个领域的适当评估提供充分可靠的依据,除非仔细阅读原始文献。这本期刊通过发表权威的、客观的、全面的跨学科评论文章,侧重于制剂和递送系统,来填补这一空白。邀请和贡献的文章都接受同行评审。

| 指标 | 当前值 | 近三年趋势 |
|---|---|---|
| JCR分区 | Q3 | 暂无 |
| 影响因子区间 | 1-3 | 暂无 |